MedPath

Attenuation of Hemodynamic Response to Laryngoscopy and Endotracheal Intubation With Single Dose of Dexmedetomidine in Hypertensive Patients.

Not Applicable
Completed
Conditions
Stress Response During Laryngoscopy Intubation
Interventions
Drug: Dexmedetomidine
Drug: sterile saline
Registration Number
NCT03204006
Lead Sponsor
Assiut University
Brief Summary

Attenuation of Hemodynamic Response to Laryngoscopy and Endotracheal Intubation With Single Dose of Dexmedetomidine in Hypertensive Patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
70
Inclusion Criteria
    • Age group 20-60 years
  • ASA grade 1 and 2
  • control hypertensive patients.
Read More
Exclusion Criteria
    • Consent not given
  • ASA Grade 3 and 4
  • history of myocardial ischemia or infarction, or had an abnormal ECG on admission to the hospital
  • Patients with cardiovascular, pulmonary, hepatic, and renal disease.
  • Patients on B blockers.
  • patients with difficult airway; laryngoscopy and intubation time more than 20 s, or requiring more than two attempts will be exclude from the study.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Dexmedetomidine groupDexmedetomidine35 patients will receive dexmedetomidine 0.5 µg/kg was administered intravenously using a syringe pump over 10 min sterile saline pre-induction of anesthesia.
Control groupsterile saline35 patients will receive sterile saline 0.5 µg/kg was administered intravenously using a syringe pump over 10 min pre-induction of anesthesia.
Primary Outcome Measures
NameTimeMethod
heart ratethrough first 15 min post-induction of anesthesia
Secondary Outcome Measures
NameTimeMethod
systolic blood pressurethrough first 15 min post-induction of anesthesia
diastolic blood pressurethrough first 15 min post-induction of anesthesia

Trial Locations

Locations (1)

Assiut University Hospital

🇪🇬

Assiut, Egypt

© Copyright 2025. All Rights Reserved by MedPath